SCHEMBL9950395

SCHEMBL9950395

O=C(N[C@H]1C[C@@H](CN2CCS(=O)(=O)CC2)C1)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ CTSL P07711 1/20 0.49
▸ CTSB P07858 1/20 0.49
▸ CTSK P43235 1/20 0.49
▸ TSHR P16473 1/20 0.48
▸ EPHX1 P07099 1/20 0.46
▸ HSD11B1 P28845 1/20 0.45
▸ DPP4 P27487 6/20 0.45
▸ DPP7 Q9UHL4 6/20 0.45
▸ KCNH2 Q12809 3/20 0.45
▸ TLR4 O00206 1/20 0.43
▸ KDM1A O60341 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ CPB1 P15086 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9950324 1.00 ALDH1A1 (0.50) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1933160 0.85 ALDH1A1 (0.54) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1933158 0.85 ALDH1A1 (0.54) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL13720769 0.81 CCR5 (0.38) CTSLCTSBCTSK
SCHEMBL14370876 0.79 ALDH1A1 (0.68) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1442247 0.78 ALDH1A1 (0.62) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL13469279 0.78 ALDH1A1 (0.62) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1442248 0.78 ALDH1A1 (0.62) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL13580104 0.77 ALDH1A1 (0.62) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1441840 0.77 ALDH1A1 (0.45) ALDH1A1GAACTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2683722-A1 FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS Novartis AG (CH) 2014-01-15 — — EP disclosed
US-20130338152-A1 FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS IRM LLC (BM) 2013-12-19 — — US disclosed
WO-2012120469-A1 FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS NOVARTIS AG (CH) 2012-09-13 — — WO disclosed
US-20120165310-A1 ETHER DERIVATIVES OF BICYCLIC HETEROARYLS NOVARTIS AG (CH) 2012-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338152-A1 FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS IGF1R, IGFBP1, IGFBP2 ALDH1A1 1566/4885GAA 1731/4885CTSL 3370/4885
US-20120165310-A1 ETHER DERIVATIVES OF BICYCLIC HETEROARYLS ETV6, CYP11B2, CYP11B1 ALDH1A1 477/4885GAA 891/4885CTSL 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback